AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6374085 — intervention group
Group type: EXPERIMENTAL
Intervention: Dicyclomine hydrochloride
Number of subjects: 48
Study 6374085 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 31175560 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral subcostal transversus abdominis plane block (TAP)
Number of subjects: 45
Study 31175560 — intervention group
Group type: COMPARATOR
Intervention: Trocar site infiltration
Number of subjects: 45
Study 29656913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention churches (n=59)
Number of subjects: 1308
Study 29656913 — intervention group
Group type: COMPARATOR
Intervention: Control churches (delayed intervention)
Number of subjects: 1308
Study 25804277 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk
Number of subjects: 20
Study 25804277 — intervention group
Group type: COMPARATOR
Intervention: Typical formula
Number of subjects: 20
Study 25804277 — intervention group
Group type: EXPERIMENTAL
Intervention: Other formulas
Number of subjects: 20
Study 24520548 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg)
Number of subjects: 70
Study 24520548 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 70
Study 21135626 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents exposed to media messages
Number of subjects: 404
Study 21135626 — intervention group
Group type: COMPARATOR
Intervention: Children of unexposed parents
Number of subjects: 404
Study 19729114 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic strategy (group B) - patients who systematically underwent pre-operative coronary angiography
Number of subjects: 208
Study 19729114 — intervention group
Group type: COMPARATOR
Intervention: Selective strategy (group A) - coronary angiography performed based on noninvasive tests
Number of subjects: 208
Study 19729114 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic strategy (group B)
Number of subjects: 208
Study 17679727 — intervention group
Group type: EXPERIMENTAL
Intervention: PLD + bortezomib
Number of subjects: 646
Study 17679727 — intervention group
Group type: COMPARATOR
Intervention: bortezomib
Number of subjects: 646
Study 15123861 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbitone (5 mg/kg/day for 3 days)
Number of subjects: 75
Study 15123861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 15123861 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbitone
Number of subjects: 75
Study 11374495 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise stress test
Number of subjects: 42
Study 11374495 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine stress test
Number of subjects: 42
Study 11374495 — intervention group
Group type: COMPARATOR
Intervention: Combined exercise and dobutamine testing
Number of subjects: 42
Study 9566630 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) based on propofol and alfentanil
Number of subjects: 30
Study 9566630 — intervention group
Group type: COMPARATOR
Intervention: Balanced anesthesia (BA) based on nitrous oxide, isoflurane and fentanyl
Number of subjects: 30
Study 9566630 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVA
Number of subjects: 30
Study 9566630 — intervention group
Group type: COMPARATOR
Intervention: BA
Number of subjects: 30
Study 9471197 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymostimulin + concurrent hyperfractionated carboplatin and irradiation
Number of subjects: 36
Study 9471197 — intervention group
Group type: COMPARATOR
Intervention: Concurrent hyperfractionated carboplatin and irradiation
Number of subjects: 36
Study 1826920 — intervention group
Group type: EXPERIMENTAL
Intervention: Back school therapy
Number of subjects: 0
Study 1826920 — intervention group
Group type: COMPARATOR
Intervention: Spinal manipulative therapy
Number of subjects: 0
Study 7074980 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg naloxone administered to women on days 2‐4 of the puerperium
Number of subjects: 6
Study 31641322 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-oriented cardiovascular risk reduction interventions
Number of subjects: 11
Study 31641322 — intervention group
Group type: EXPERIMENTAL
Intervention: Study participation
Number of subjects: 11
Study 29895376 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg of elemental calcium as calcium citrate
Number of subjects: 27
Study 29895376 — intervention group
Group type: COMPARATOR
Intervention: Calcium chloride (control)
Number of subjects: 27
Study 26817642 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathogen-reduced platelet concentrates treated by the Mirasol system
Number of subjects: 618
Study 26817642 — intervention group
Group type: COMPARATOR
Intervention: Standard plasma-stored platelet concentrates
Number of subjects: 618
Study 24793078 — intervention group
Group type: EXPERIMENTAL
Intervention: ABH Gel (lorazepam, diphenhydramine, haloperidol)
Number of subjects: 0
Study 24793078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24793078 — intervention group
Group type: EXPERIMENTAL
Intervention: ABH Gel
Number of subjects: 0
Study 24793078 — intervention group
Group type: EXPERIMENTAL
Intervention: ABH Gel and Placebo
Number of subjects: 0
Study 22560128 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 22
Study 22560128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 20881623 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical examinations by an occupational medicine physician
Number of subjects: 111
Study 20881623 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical examinations by a physical therapist
Number of subjects: 111
Study 20881623 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical examinations including symptoms for elbow and hand/wrist tests
Number of subjects: 111
Study 18574656 — intervention group
Group type: EXPERIMENTAL
Intervention: CFPN-PI for 5 days (9-10 mg/kg/day, three times a day)
Number of subjects: 250
Study 18574656 — intervention group
Group type: EXPERIMENTAL
Intervention: CFPN-PI for 10 days (three times a day)
Number of subjects: 250
Study 18574656 — intervention group
Group type: COMPARATOR
Intervention: AMPC for 10 days (three times a day)
Number of subjects: 250
Study 15830233 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta(9)-THC 10 mg
Number of subjects: 10
Study 15830233 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta(9)-THC 20 mg
Number of subjects: 10
Study 15830233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 15830233 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta(9)-THC (10 and 20 mg)
Number of subjects: 10
Study 11937721 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% sucrose solution
Number of subjects: 0
Study 11937721 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sterile water)
Number of subjects: 0
Study 9548151 — intervention group
Group type: EXPERIMENTAL
Intervention: FSH treatment (60 patients)
Number of subjects: 90
Study 9548151 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (30 patients)
Number of subjects: 90
Study 9548151 — intervention group
Group type: EXPERIMENTAL
Intervention: FSH treatment
Number of subjects: 90
Study 8160602 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (400 mg/day)
Number of subjects: 101
Study 8160602 — intervention group
Group type: COMPARATOR
Intervention: Mexiletine (720 mg/day)
Number of subjects: 101
Study 2963532 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g vitamin E/d
Number of subjects: 9
Study 2963532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 30587210 — intervention group
Group type: EXPERIMENTAL
Intervention: Field assessment
Number of subjects: 1080
Study 30587210 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital transport
Number of subjects: 1080
Study 30587210 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD code assessment
Number of subjects: 1080
Study 27096218 — intervention group
Group type: EXPERIMENTAL
Intervention: Talking and Learning for Kindergarten program (Edwards, Rosin, Gross, & Chen, 2013)
Number of subjects: 2
Study 27096218 — intervention group
Group type: COMPARATOR
Intervention: Kindness Curriculum (Flook, Goldberg, Pinger, & Davidson, 2014)
Number of subjects: 2
Study 24401815 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.45 g/d eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
Number of subjects: 367
Study 24401815 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9 g/d eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
Number of subjects: 367
Study 24401815 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8 g/d eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
Number of subjects: 367
Study 24401815 — intervention group
Group type: COMPARATOR
Intervention: Olive oil placebo
Number of subjects: 367
Study 22632798 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 40
Study 22632798 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with nitrous oxide
Number of subjects: 40
Study 22632798 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with air
Number of subjects: 40
Study 22632798 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane with air
Number of subjects: 40
Study 22632798 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane with nitrous oxide
Number of subjects: 40
Study 20571135 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian network for error detection
Number of subjects: 200
Study 20571135 — intervention group
Group type: COMPARATOR
Intervention: Laboratory experts
Number of subjects: 200
Study 18191112 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (up to 14 weeks)
Number of subjects: 1809
Study 15696076 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (100 microg twice daily)
Number of subjects: 126
Study 15696076 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (5-10 mg nightly depending on age)
Number of subjects: 126
Study 15696076 — intervention group
Group type: COMPARATOR
Intervention: Neither medication
Number of subjects: 126
Study 14521805 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly doses of cisplatin
Number of subjects: 0
Study 14521805 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 5‐fluorouracil and cisplatin
Number of subjects: 0
Study 14521805 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurgical preoperative staging with positron emission tomography and sentinel lymph node evaluation
Number of subjects: 0
Study 10231100 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 200 mg once daily for 6 weeks
Number of subjects: 41
Study 10231100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 8542158 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled glucocorticoid (budesonide 800 micrograms twice daily for 3 weeks)
Number of subjects: 11
Study 8542158 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 11
Study 1468295 — intervention group
Group type: EXPERIMENTAL
Intervention: Premixed insulins
Number of subjects: 64
Study 1468295 — intervention group
Group type: COMPARATOR
Intervention: Extemporarily mixed insulins
Number of subjects: 64
Study 1468295 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro skills test for insulin preparation
Number of subjects: 64
Study 1468295 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood glucose profiles and HbA1c
Number of subjects: 64
Study 6398781 — intervention group
Group type: EXPERIMENTAL
Intervention: Urokinase: 800,000 CTA units/day for three days followed by oral anticoagulants
Number of subjects: 29
Study 6398781 — intervention group
Group type: COMPARATOR
Intervention: Heparin: mean daily dose 30,000 units for seven days followed by oral anticoagulants
Number of subjects: 29
Study 6398781 — intervention group
Group type: EXPERIMENTAL
Intervention: Urokinase: 3,300,000 CTA units in 12 hours followed by oral anticoagulants
Number of subjects: 29
Study 30758694 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D convolutional neural networks applied to CTA-SI
Number of subjects: 60
Study 30758694 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral hemispheric comparison as an input feature
Number of subjects: 60
Study 30758694 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-contrast computed tomography (NCCT) as an input feature
Number of subjects: 60
Study 29084828 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab-containing chemotherapy
Number of subjects: 283
Study 29084828 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 283
Study 29084828 — intervention group
Group type: EXPERIMENTAL
Intervention: DpR (deepness of response)
Number of subjects: 283
Study 27002706 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex Training (CT)
Number of subjects: 18
Study 27002706 — intervention group
Group type: COMPARATOR
Intervention: Block Training (BT)
Number of subjects: 18
Study 27002706 — intervention group
Group type: COMPARATOR
Intervention: Both CT and BT
Number of subjects: 18
Study 24705587 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma PTX3 levels in cases with recurrent coronary events
Number of subjects: 4159
Study 24705587 — intervention group
Group type: COMPARATOR
Intervention: Plasma PTX3 levels in controls
Number of subjects: 4159
Study 24705587 — intervention group
Group type: EXPERIMENTAL
Intervention: Low plasma PTX3 levels
Number of subjects: 4159
Study 24705587 — intervention group
Group type: EXPERIMENTAL
Intervention: PTX3 levels
Number of subjects: 4159
Study 21883507 — intervention group
Group type: EXPERIMENTAL
Intervention: CIDR‐Ovsynch
Number of subjects: 402
Study 21883507 — intervention group
Group type: EXPERIMENTAL
Intervention: CIDR, DIB, MAP with GnRH analogues
Number of subjects: 402
Study 21883507 — intervention group
Group type: COMPARATOR
Intervention: Overall treatment
Number of subjects: 402
Study 19892837 — intervention group
Group type: EXPERIMENTAL
Intervention: exendin(9-39) amide (300 pmol/kg x min iv)
Number of subjects: 10
Study 17265529 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg dl alpha‐tocopheryl acetate
Number of subjects: 29133
Study 17265529 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg beta‐carotene
Number of subjects: 29133
Study 17265529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29133
Study 15638899 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral incision of the prostate (TUIP)
Number of subjects: 80
Study 15638899 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 80
Study 15638899 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprapubic transvesical prostatectomy (TP)
Number of subjects: 80
Study 12803676 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta
Number of subjects: 0
Study 12803676 — intervention group
Group type: EXPERIMENTAL
Intervention: Glatiramer acetate
Number of subjects: 0
Study 12803676 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Number of subjects: 0
Study 12803676 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins (HMG CoA inhibitors)
Number of subjects: 0
Study 10599838 — intervention group
Group type: EXPERIMENTAL
Intervention: Kanji writing
Number of subjects: 8
Study 10599838 — intervention group
Group type: EXPERIMENTAL
Intervention: Kana writing
Number of subjects: 8
Study 7777738 — intervention group
Group type: EXPERIMENTAL
Intervention: Postal questionnaire dispatched on Thursday
Number of subjects: 460
Study 7777738 — intervention group
Group type: COMPARATOR
Intervention: Postal questionnaire dispatched on Saturday
Number of subjects: 460
Study 2339202 — intervention group
Group type: EXPERIMENTAL
Intervention: ONO‐3708 (thromboxane A2 antagonist) administered at a dose of 2 micrograms/kg/min
Number of subjects: 0
Study 2339202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7422258 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior vitrectomy
Number of subjects: 13
Study 31146778 — intervention group
Group type: EXPERIMENTAL
Intervention: Phased award funding mechanism for trial planning and implementation
Number of subjects: 6
Study 31146778 — intervention group
Group type: EXPERIMENTAL
Intervention: Oversight and management strategies provided by the coordinating center
Number of subjects: 6
Study 31146778 — intervention group
Group type: EXPERIMENTAL
Intervention: Documentation submitted for review by program officers/project scientists
Number of subjects: 6
Study 31146778 — intervention group
Group type: EXPERIMENTAL
Intervention: Phased award mechanism advantages
Number of subjects: 6
Study 31146778 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic approaches to identify milestones and track metrics
Number of subjects: 6
Study 28779930 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration therapy (WBV) combined with 6 different types of exercises at 30 hz frequency, 2 mm amplitude for 4 weeks
Number of subjects: 20
Study 28779930 — intervention group
Group type: COMPARATOR
Intervention: Control group performing the same exercises without vibration
Number of subjects: 20
Study 26402073 — intervention group
Group type: EXPERIMENTAL
Intervention: FCSRT-FR (free recall of the free and cued selective reminding test)
Number of subjects: 913
Study 26402073 — intervention group
Group type: EXPERIMENTAL
Intervention: FCSRT-TR (free and cued recall of the free and cued selective reminding test)
Number of subjects: 913
Study 26402073 — intervention group
Group type: COMPARATOR
Intervention: Comparison of FCSRT-FR with MMSE, CDRsb, and CVF ROCs
Number of subjects: 913
Study 23392473 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymmetric force demands with perceptually split targets
Number of subjects: 0
Study 23392473 — intervention group
Group type: EXPERIMENTAL
Intervention: Symmetric force demands with a perceptually unified target
Number of subjects: 0
Study 23392473 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice interrupted by unimanual or different bimanual conditions
Number of subjects: 0
Study 21722098 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume (26 ml) ropivacaine 1% with epinephrine
Number of subjects: 48
Study 21722098 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 48
Study 18504606 — intervention group
Group type: EXPERIMENTAL
Intervention: Tones spaced an octave apart
Number of subjects: 74
Study 18504606 — intervention group
Group type: EXPERIMENTAL
Intervention: Tones separated by a major seventh
Number of subjects: 74
Study 18504606 — intervention group
Group type: EXPERIMENTAL
Intervention: Tones separated by a minor ninth
Number of subjects: 74
Study 18504606 — intervention group
Group type: EXPERIMENTAL
Intervention: Tones separated by a major ninth
Number of subjects: 74
Study 18504606 — intervention group
Group type: EXPERIMENTAL
Intervention: Tones separated by a minor tenth
Number of subjects: 74
Study 18504606 — intervention group
Group type: EXPERIMENTAL
Intervention: Tones lasting 500 ms
Number of subjects: 74
Study 18504606 — intervention group
Group type: EXPERIMENTAL
Intervention: Tones lasting 200 ms
Number of subjects: 74
Study 16385193 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-life practice studies (e.g., Triumph project, Quadraet study, ALF-ONE study)
Number of subjects: 0
Study 16385193 — intervention group
Group type: COMPARATOR
Intervention: Randomized controlled trials
Number of subjects: 0
Study 15244498 — intervention group
Group type: EXPERIMENTAL
Intervention: Aciclovir 800 mg + MMF 1 g
Number of subjects: 15
Study 15244498 — intervention group
Group type: EXPERIMENTAL
Intervention: Valaciclovir 2 g + MMF 1 g
Number of subjects: 15
Study 15244498 — intervention group
Group type: COMPARATOR
Intervention: Valaciclovir 2 g alone
Number of subjects: 15
Study 15244498 — intervention group
Group type: COMPARATOR
Intervention: Aciclovir 800 mg alone
Number of subjects: 15
Study 15244498 — intervention group
Group type: COMPARATOR
Intervention: MMF 1 g alone
Number of subjects: 15
Study 11423451 — intervention group
Group type: EXPERIMENTAL
Intervention: Peribulbar anaesthesia
Number of subjects: 20
Study 11423451 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrobulbar anaesthesia
Number of subjects: 20
Study 11423451 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study 9251949 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam (1 g ampicillin plus 0.5 g sulbactam)
Number of subjects: 170
Study 9251949 — intervention group
Group type: COMPARATOR
Intervention: Cefotetan (1 g cefotetan)
Number of subjects: 170
Study 9251949 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam
Number of subjects: 170
Study 9251949 — intervention group
Group type: COMPARATOR
Intervention: Cefotetan
Number of subjects: 170
Study 8489308 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative drainage of the main pancreatic duct (MPD)
Number of subjects: 143
Study 8489308 — intervention group
Group type: COMPARATOR
Intervention: Non-operative treatment
Number of subjects: 143
Study 8489308 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment in randomized trial
Number of subjects: 143
Study 8489308 — intervention group
Group type: COMPARATOR
Intervention: Non-operative treatment in randomized trial
Number of subjects: 143
Study 3819810 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachytherapy (BRT)
Number of subjects: 105
Study 3819810 — intervention group
Group type: COMPARATOR
Intervention: Non-BRT
Number of subjects: 105
Study 3819810 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant Adriamycin
Number of subjects: 105
Study 28414546 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant Behavior Program (IBP)
Number of subjects: 60
Study 28414546 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study 27296661 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative combination of formal and peer education followed by FibroScan
Number of subjects: 52
Study 27296661 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 52
Study 24914779 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 75 mg twice daily for 5 days
Number of subjects: 135
Study 24914779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 22453769 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixmyelocel-T
Number of subjects: 77
Study 22453769 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77